Recent studies have further suggested that human TAAR1 is expressed in several brain regions but not in the olfactory epithelium; TAAR1 was proposed as a promising therapeutic target for the treatment of schizophrenia, psychosis in Parkinson’s disease, substance abuse, metabolic syndrome, and obesity [53, 71, 72]. The gene discussed is TAAR1; the disease is schizophrenia.